Delivery Order SPE2DB24D9802-SPE2DB25FJKTX

This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 90 count tablets of the drug Anastrozole 1 mg. The award, valued at $1,298.94, is part of a larger Indefinite Delivery Contract with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...

The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred twenty-one thousand two hundred twenty-six dollars ($121,226) to Amerisourcebergen Drug Corporation for the supply of thirty (30) 1mg tablets of Anastrozole per package. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 25, 2023 through July 26, 2023. No major subcontractors or set aside designations were indicated. This...

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,811.39 firm fixed price delivery order is for the supply of ANASTROZOLE 1 MG TABLET 90S, a medication used to treat breast cancer. The contract has an ultimate completion date of February 8, 2023 and is not set aside for any specific business type. Amerisourcebergen Drug Corp is a subsidiary of the parent...

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,175.58 firm fixed-price contract is for the delivery of 4,562,781,280 units of Anastrozole 1 mg tablets. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, as well as a $750,000...

This federal contract award is for the delivery of Anastrozole 1 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,034.51, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026. This IDC...

The Defense Logistics Agency awarded a $854.94 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 90 1 mg tablets of Anastrozole, an aromatase inhibitor used to treat breast cancer. The order was placed under an existing prime vendor contract vehicle to provide pharmaceutical products and services to DOD customers. Performance will take place in Conshohocken, Pennsylvania with all items to be delivered between August 18-21, 2023. No set aside designation or...

This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $30,588.13, is for the delivery of 4560629092 - ANASTROZOLE 1 MG TABLET 30S. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This...

This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 90-count tablets of the medication Anastrozole 1 mg, with a ceiling value of $2,088.87 and a completion date of May 10, 2023. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...

The Defense Logistics Agency awarded a $64,020 firm fixed price delivery order to AmerisourceBergen Drug Corporation for the supply of 30 boxes containing 1 mg tablets of anastrozole, an aromatase inhibitor used as a breast cancer treatment. The order was placed under an existing Prime Vendor contract vehicle and will be fulfilled from AmerisourceBergen's distribution center located in Conshohocken, Pennsylvania by July 28, 2023 to support the Department of Defense's pharmaceutical needs. No...

This is a $2,936.90 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,560,334 units of the drug Anastrozole 1 mg tablets, which are used to treat certain types of breast cancer. The contract has a firm fixed price and a completion date of March 22, 2023. There is no set-aside designation indicated for this contract. AmerisourceBergen holds a...